Fish Nutrient Supplementation in High-intensity Functional Training
Effects of a Nutritional Supplement of Proteins, ω3 Fatty Acids and Vitamin D on Physical Performance, Body Composition and Biochemical Profile of Persons Following High-intensity Functional Training
1 other identifier
interventional
25
1 country
1
Brief Summary
Nowadays, many persons who exercise consume dietary supplements. Previous scientific studies have found that protein supplementation increases muscle mass when combined with an exercise program. In addition, vitamin D probably improves performance and muscle function. Likewise, ω3 fatty acids, apart from improving cardiovascular function, may also increase protein synthesis and performance. Thus, the aim of this study is to investigate the efficacy of a novel aquaculture-based sport supplement of proteins, ω3 fatty acids and vitamin D on physical performance, body composition, and the biochemical profile of persons following high-intensity functional training (HIFT). The efficacy of the experimental supplement (E) will be compared with whey protein (W) and maltodextrin (a carbohydrate) as placebo (P). Thirty healthy trained individuals (15 male and 15 female), aged 18-35, will take E, W, and P during three 6-week periods of HIFT (a different supplement each period) with three workouts a week and a washout (no supplement) period of 2 weeks between supplementation periods. E is a combination of powder, containing protein and vitamin D, and capsules containing ω3 fatty acids. When on E, participants will receive 0.6 g protein/kg body weight, 20 μg vitamin D, and 1.8 g ω3 fatty acids daily. When on W, they will receive 0.6 g protein/kg body weight and, when on P, they will receive 0.6 g maltodextrin/kg body weight daily. The order of E, W, and P will be random and counterbalanced. Throughout the study, participants will be on isoenergetic nutritional plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition prior to the first supplementation period, between periods, and after the third period. Also, blood amino acids, fatty acid acids, vitamin D, hematology, biochemistry, and hormones will be measured. To avoid bias, assessors will not know which supplement each participant is taking during each period. The main hypotheses of the study are: 1) Consumption of E will increase lean body mass compared to W and P; 2) consumption of E will improve muscle strength, muscle endurance, and aerobic capacity compared to W and P; and 3) consumption of E will result in a better blood amino acid, fatty acid, and vitamin D profile.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2021
CompletedFirst Submitted
Initial submission to the registry
April 22, 2022
CompletedFirst Posted
Study publicly available on registry
June 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedOctober 5, 2023
October 1, 2023
1.4 years
April 22, 2022
October 3, 2023
Conditions
Outcome Measures
Primary Outcomes (12)
Plasma amino acid profile pre-supplementation
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Within 2 days before the beginning of supplementation.
Plasma amino acid profile post-supplementation
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Within 2 days after the end of supplementation.
Whole-blood fatty acid profile pre-supplementation
Whole-blood fatty acid profile (that is, the concentration of each individual fatty acid) will be determined by gas chromatography.
Within 2 days before the beginning of supplementation.
Whole-blood fatty acid profile post-supplementation
Whole-blood fatty acid profile (that is, the concentration of each individual fatty acid) will be determined by gas chromatography.
Within 2 days after the end of supplementation.
Maximal dynamic strength of shoulder muscles pre-supplementation
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Within 2 weeks before the beginning of supplementation.
Maximal dynamic strength of shoulder muscles post-supplementation
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Within 2 weeks after the end of supplementation.
Force-velocity relationship of knee flexors and extensors pre-supplementation
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of knee flexors and extensors post-supplementation
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Within 2 weeks after the end of supplementation.
Aerobic fitness pre-supplementation
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Within 2 weeks before the beginning of supplementation.
Aerobic fitness post-supplementation
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Within 2 weeks after the end of supplementation.
Lean and fat mass pre-supplementation
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Within 2 weeks before the beginning of supplementation.
Lean and fat mass post-supplementation
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Within 2 weeks after the end of supplementation.
Secondary Outcomes (16)
Plasma vitamin D concentration pre-supplementation
Within 2 days before the beginning of supplementation.
Plasma vitamin D concentration post-supplementation
Within 2 days after the end of supplementation.
Muscle endurance pre-supplementation
Within 2 weeks before the beginning of supplementation.
Muscle endurance post-supplementation
Within 2 weeks after the end of supplementation.
Force-velocity relationship of shoulder muscles pre-supplementation
Within 2 weeks before the beginning of supplementation.
- +11 more secondary outcomes
Study Arms (6)
Fish nutrients - Whey protein - Maltodextrin
OTHERParticipants will receive fish nutrients, whey protein, and maltodextrin in this order.
Fish nutrients - Maltodextrin - Whey protein
OTHERParticipants will receive fish nutrients, maltodextrin, and whey protein in this order.
Whey protein - Fish nutrients - Maltodextrin
OTHERParticipants will receive whey protein, fish nutrients, and maltodextrin in this order.
Whey protein - Maltodextrin - Fish nutrients
OTHERParticipants will receive whey protein, maltodextrin, and fish nutrients in this order.
Maltodextrin - Fish nutrients - Whey protein
OTHERParticipants will receive maltodextrin, fish nutrients, and whey protein in this order.
Maltodextrin - Whey protein - Fish nutrients
OTHERParticipants will receive maltodextrin, whey protein, and fish nutrients in this order.
Interventions
Intake of fish protein, omega-3 fatty acids, and vitamin D
Intake of whey protein
Intake of maltodextrin
Eligibility Criteria
You may qualify if:
- Regular training (mixed endurance and resistance training 3-6 times a week, 50 min each session, for the past 4-6 months) as assessed by gym records or questionnaires.
- Clearance from a pathologist or cardiologist to perform maximal exercise.
- Mixed isoenergetic diet for the past 4-6 months.
You may not qualify if:
- Smoking (even one cigarette or nicotine-containing device over the past 6 months).
- Any injuries to the musculoskeletal system that could interfere with the execution of training.
- Chronic disease.
- Fish or oyster allergy.
- Milk allergy.
- Pregnancy, lactation or planning a pregnancy within the duration of the study.
- Regular use of prescription medicine or supplements that might affect muscle function or recovery over the past month.
- Intermittent or religious fasting.
- Any vegetarian, ketogenic and protein diet.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aristotle University Of Thessalonikilead
- European Commissioncollaborator
Study Sites (1)
Laboratory of Evaluation of Human Biological Performance
Thessaloniki, 57001, Greece
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Participants are instructed not to disclose the supplement they are taking to their trainers, investigators, or outcome assessors.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2022
First Posted
June 2, 2022
Study Start
November 8, 2021
Primary Completion
March 31, 2023
Study Completion
September 30, 2023
Last Updated
October 5, 2023
Record last verified: 2023-10